Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relay Medical Corp. (C:RELA)

Business Focus: Medical Diagnostic & Testing Equipment

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for RELA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 09, 2019 17:00 ET
Relay Medical Announces Closing of Second Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company has completed the second tranche of the private placement financing (the "Offering") for gross proceeds of $542,000 through the issuance of 2,710,000 Units (each, a "Unit") at a price of $0.20 per unit. The aggregate gross proceeds raised pursuant to the first and second tranches of the Offering was $2,074,500 through the issuance of 10,372,500 Units.
Read full article
Jul 02, 2019 16:30 ET
Relay Medical Acquires License to Medical-Grade Cloud Software from Fio Corporation
Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the acquisition of rights to a medical-grade cloud software platform, from Fio Corporation, which develops sophisticated healthcare IT solutions for decentralized and mobile settings across the continuum of care, globally. The software, to be marketed as Relay MedNet, has been acquired to substantially accelerate Pharmatrac and HemoPalm development and as an offering that stands alone and in combination with future Relay products. The Company also reports on the appointment of Adam Liederman as Chief Operating Officer.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-1.10
--
--
Price to Sales - TTM
--
--
13.27
Price to Book - most recent quarter
5.10
3.06
2.74
Price to Cash Flow per share - TTM
--
--
12.70
Price to Free Cash Flow per share - TTM
--
--
18.87
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jul 31, 201925,145-18,319
Jul 15, 201943,464-21,536
Jun 30, 201965,00015,980
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Relay Medical Corp, formerly ChroMedX Corp, is a Canada-based medical technology company. The Company focuses on the development of handheld medical devices for In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). The Company's devices are protected by issued United States and pending international patents, in the medical diagnostics and research field, dealing with blood collection, analysis and plasma/serum processing. The Company has the following platform technologies: HemoPalm and Automated Ultra Filtration (AUF) technology. Its HemoPalm platform is a blood analysis system consisting of a handheld analyzer and a suite of disposable single use cartridges. Its UAF technology allows the preparation of ultra-filtrates of serum and plasma samples, for measurement of therapeutic drugs and hormones to be done on an automated system.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $RELA.CA

  • No tweets found